Arquitos Capital reports a -7.2% Q1 return, highlighting biotech liquidations and Liquidia Corporation. Read the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results